News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Buy call on Boeing ahead of an expected cash-flow inflection over the next 12–18 months.
  • FAA approval of the 737 MAX 7 and new defense awards provide near-term catalysts for Boeing.
  • Algonquin Power's move to a regulated-only profile stabilizes cash flow and underpins a 4.6% yield.
  • Technical setup and valuation near support make Algonquin a measured swing-long with a defined stop.
  • VXUS is pitched as a tactical buy for international diversification, covering 8,700+ non-U.S. stocks and a 2.5% yield.
  • VXUS's bullish momentum and roughly 4.6M average daily volume support trade execution for retirement portfolios.

Latest Articles

BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs

BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs

BeyondSpring Inc. announced new preclinical data demonstrating that Plinabulin significantly improves both the anticancer efficacy and safety profile of leading antibody-drug conjugate (ADC) therapies. Presented at AACR 2026, the data show enhanced tumor response rates, longer survival, and reduced toxicities when Plinabulin is combined with ADCs w…

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc., a medical technology company specializing in neuromodulation therapies, announced that four additional health insurers have adopted medical policy coverage for its IB-Stim Percutaneous Electrical Nerve Field Stimulation (PENFS) device. This expansion brings approximately 1.25 million more covered lives across several U.S. states, en…

Lantronix to Report Fiscal 2026 Third Quarter Results on May 6, 2026

Lantronix to Report Fiscal 2026 Third Quarter Results on May 6, 2026

Lantronix Inc., a Nasdaq-listed leader in Edge AI and Industrial IoT solutions, announced it will report its fiscal third quarter 2026 financial results on May 6, 2026, followed by a management-hosted conference call and webcast. The company provides intelligent computing and secure connectivity solutions for mission-critical applications across se…

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

Nutriband Inc.'s CEO Gareth Sheridan appeared on the Jack Neel Podcast to discuss the ongoing US fentanyl crisis and present Nutriband's AVERSA™ technology, which aims to improve safety by preventing abuse and misuse of transdermal drug patches like fentanyl. The technology is patent-protected internationally and the company is developing an abuse-…

Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”

Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”

Rafael Holdings, Inc. announced an exclusive licensing agreement with MIT for a patent covering cyclodextrin use in Alzheimer's patients carrying the ApoE4 gene variant. This expands the intellectual property portfolio for Trappsol® Cyclo™, which has shown promising preclinical effects on cholesterol transport, tau pathology reduction, and cognitiv…

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

Certara, Inc. announced an agreement to sell its Regulatory and Medical Writing business to Veristat for up to $135 million, aiming to sharpen focus and accelerate investments in its Model-Informed Drug Development (MIDD) and Clinical Intelligence platforms. The Regulatory and Medical Writing segment generated $50 million in revenue and $17 million…

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

Nurix Therapeutics announced encouraging preclinical results from multiple oncology programs at AACR 2026, demonstrating the potential of their targeted protein degradation pipeline. Key programs include the pan-mutant BRAF degrader NRX-0305, CBL-B intramolecular glue inhibitors (NX-1607), and Aurora Kinase A degrader NRX-4972. The data show enhanc…

Ocular Therapeutix™ to Host Investor Day on June 17, 2026

Ocular Therapeutix™ to Host Investor Day on June 17, 2026

Ocular Therapeutix, a biopharmaceutical company specializing in retina disease treatments, announced an Investor Day event scheduled for June 17, 2026 in New York City with virtual access available. The event will feature senior leadership and key opinion leaders discussing its pipeline including the Phase 3 trials of AXPAXLI for wet AMD and diabet…

Australia Orders Major Gaming Platforms to Disclose Child Protection Measures

Australia Orders Major Gaming Platforms to Disclose Child Protection Measures

Australia's online safety regulator has served legally enforceable transparency notices on several leading gaming platforms, requesting detailed information about measures to prevent grooming, sexual extortion and radicalisation of children. Platforms named include Roblox, Microsoft’s Minecraft, Epic Games’ Fortnite and Valve’s Steam. Companies fac…

Ceasefire Extended, Markets Look Past the Strait as Tech Drives Sentiment

Ceasefire Extended, Markets Look Past the Strait as Tech Drives Sentiment

President Donald Trump announced a unilateral extension of a ceasefire in the Iran conflict beyond a Wednesday deadline, but participants on the other side have not clearly endorsed the move. Oil markets registered only muted gains, while global equity markets and futures leaned toward optimism driven by strength in technology stocks. Key macro and…

Structural Narrowness Limits Depth of Any UK Market Rally

Structural Narrowness Limits Depth of Any UK Market Rally

UBS analysts say the U.K. equity market is unusually concentrated, with the effective number of influential stocks in the low teens versus more than 50 in Europe. That structural crowding - concentrated ownership by U.S. investors and sector-level positioning in Energy and Consumer names - reduces the market's capacity to sustain a broad-based adva…

Bank Indonesia Holds Policy Rate at 4.75% While Focusing on Rupiah Strength

Bank Indonesia Holds Policy Rate at 4.75% While Focusing on Rupiah Strength

Bank Indonesia maintained its policy rate at 4.75% on Wednesday, prioritizing measures to strengthen the Indonesian rupiah, according to a Bank of America research note. The central bank did not rule out further tightening but indicated it may rely on alternative instruments such as steering SRBI yields and intervening in offshore non-deliverable f…

CDC Withholds Vaccine Effectiveness Report From Agency Journal

CDC Withholds Vaccine Effectiveness Report From Agency Journal

A previously delayed internal CDC report indicating COVID-19 vaccines halved emergency department visits and hospitalizations among healthy adults this past winter has been blocked from appearing in the agency's primary scientific journal. The report's findings could not be independently verified. The Department of Health and Human Services did not…

Softer Growth and Cooling Inflation Keep Door Open for Fed Rate Cuts, UBS Says

Softer Growth and Cooling Inflation Keep Door Open for Fed Rate Cuts, UBS Says

UBS expects the U.S. Federal Reserve to be positioned to cut interest rates before year-end, citing cooler underlying inflation in March and indications of labour demand softening. The bank also noted that a likely more dovish Fed board composition and policymakers' preference for a policy rate nearer 3% mean markets may be pricing policy too tight…

Pope Decries Wealth Gap in Packed Mongomo Mass on Final Full Day of Africa Visit

Pope Decries Wealth Gap in Packed Mongomo Mass on Final Full Day of Africa Visit

On the last full day of a four-nation trip, Pope Leo spoke strongly against economic inequality and poor detention conditions while visiting Equatorial Guinea. The pope celebrated Mass in Mongomo before travelling to other cities on a tightly scheduled itinerary that has covered nearly 18,000 km and included multiple flights. His programme in the c…

Indian Equities Slip as Tech, FMCG and Healthcare Weigh on Nifty

Indian Equities Slip as Tech, FMCG and Healthcare Weigh on Nifty

Indian benchmark indices closed lower on Wednesday as declines in Technology, Fast Moving Consumer Goods and Healthcare sectors pressured markets. The Nifty 50 fell 0.81% and the BSE Sensex slipped 0.95%. Notable moves included a sharp drop in HCL Technologies to 52-week lows and a rally in NTPC to 52-week highs. Broader market breadth favored adva…